Cargando…

Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell Carcinoma

BACKGROUND: Antiangiogenic agents that specifically target vascular endothelial growth factor receptor (VEGFR), such as sunitinib, have been utilized as the standard therapy for metastatic clear cell renal cell carcinoma (ccRCC) patients. However, most patients eventually show no responses to the ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Yuang, Chen, Xinglin, Ren, Xiaohan, Wang, Bao, Zhang, Qian, Bu, Hengtao, Qian, Jian, Shao, Pengfei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299280/ https://www.ncbi.nlm.nih.gov/pubmed/34306023 http://dx.doi.org/10.3389/fgene.2021.680369

Ejemplares similares

Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma
por: Wang, Bao, et al.
Publicado: (2022)

NCKAP1 is a Prognostic Biomarker for Inhibition of Cell Growth in Clear Cell Renal Cell Carcinoma
por: Chen, Jiasheng, et al.
Publicado: (2022)

Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma
por: Sun, Ming, et al.
Publicado: (2022)

C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma
por: Yao, Wentao, et al.
Publicado: (2023)

Gene Signature Associated With Bromodomain Genes Predicts the Prognosis of Kidney Renal Clear Cell Carcinoma
por: Lu, Junwan, et al.
Publicado: (2021)

Acyl-CoA Thioesterase 8 and 11 as Novel Biomarkers for Clear Cell Renal Cell Carcinoma
por: Xu, Chao-Liang, et al.
Publicado: (2020)

Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma
por: Gan, Kai, et al.
Publicado: (2022)

Promising Epigenetic Biomarkers Associated With Cancer-Associated-Fibroblasts for Progression of Kidney Renal Clear Cell Carcinoma
por: You, Yongke, et al.
Publicado: (2021)

Prognostic significance of CKAP2L expression in patients with clear cell renal cell carcinoma
por: Liu, Zhi, et al.
Publicado: (2023)

HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma
por: Maroto, P, et al.
Publicado: (2017)

Cuproptosis-related gene FDX1 as a prognostic biomarker for kidney renal clear cell carcinoma correlates with immune checkpoints and immune cell infiltration
por: Yao, Yimin, et al.
Publicado: (2023)

Identification of a Six-Gene Prognostic Signature Characterized by Tumor Microenvironment Immune Profiles in Clear Cell Renal Cell Carcinoma
por: Zhang, Lu, et al.
Publicado: (2021)

Ferroptosis-Related Gene-Based Prognostic Model and Immune Infiltration in Clear Cell Renal Cell Carcinoma
por: Zhao, Guo-Jiang, et al.
Publicado: (2021)

Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database
por: Xiao, Guan-Fa, et al.
Publicado: (2020)

Prognostic Role of TMED3 in Clear Cell Renal Cell Carcinoma: A Retrospective Multi-Cohort Analysis
por: Ha, Mihyang, et al.
Publicado: (2019)

Transcriptome Analyses Identify an RNA Binding Protein Related Prognostic Model for Clear Cell Renal Cell Carcinoma
por: Wu, Yue, et al.
Publicado: (2021)

Identification of a Metastasis-Associated Gene Signature of Clear Cell Renal Cell Carcinoma
por: Gao, Suhua, et al.
Publicado: (2021)

Construction of a novel prognostic signature based on the composition of tumor-infiltrating immune cells in clear cell renal cell carcinoma
por: Yu, Weiwei, et al.
Publicado: (2022)

A Prognostic Signature for Clear Cell Renal Cell Carcinoma Based on Ferroptosis-Related lncRNAs and Immune Checkpoints
por: Dong, Yunze, et al.
Publicado: (2022)

Systematic Construction and Validation of a Novel Macrophage Differentiation–Associated Prognostic Model for Clear Cell Renal Cell Carcinoma
por: Liu, Chen, et al.
Publicado: (2022)

Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma
por: Xu, Shengxian, et al.
Publicado: (2022)

Identification of subtypes of clear cell renal cell carcinoma and construction of a prognostic model based on fatty acid metabolism genes
por: Nie, Shiwen, et al.
Publicado: (2022)

A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma
por: Chen, Zhuo, et al.
Publicado: (2022)

Prognostic prediction of clear cell renal cell carcinoma based on lipid metabolism-related lncRNA risk coefficient model
por: Qu, GenYi, et al.
Publicado: (2023)

Cell Polarity Protein Pals1-Associated Tight Junction Expression Is a Favorable Prognostic Marker in Clear Cell Renal Cell Carcinoma
por: Li, Pingping, et al.
Publicado: (2020)

Identification of autophagy-related long non-coding RNA prognostic and immune signature for clear cell renal cell carcinoma
por: Cui, Yankang, et al.
Publicado: (2021)

AC010973.2 promotes cell proliferation and is one of six stemness-related genes that predict overall survival of renal clear cell carcinoma
por: Liu, Yingqing, et al.
Publicado: (2022)

Identification of a Novel Epigenetic Signature CHFR as a Potential Prognostic Gene Involved in Metastatic Clear Cell Renal Cell Carcinoma
por: Chen, Xiangling, et al.
Publicado: (2021)

Prognostic Characteristics and Immune Effects of N(6)-Methyladenosine and 5-Methylcytosine-Related Regulatory Factors in Clear Cell Renal Cell Carcinoma
por: Li, Lei, et al.
Publicado: (2022)

Prognostic and Diagnostic Values of Semaphorin 5B and Its Correlation With Tumor-Infiltrating Immune Cells in Kidney Renal Clear-Cell Carcinoma
por: Ding, Junping, et al.
Publicado: (2022)

Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma
por: Zhong, Ming, et al.
Publicado: (2022)

Establishment of a prognostic ferroptosis- and immune-related long noncoding RNAs profile in kidney renal clear cell carcinoma
por: Han, Zhijun, et al.
Publicado: (2022)

The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
por: Zhang, Lishuo, et al.
Publicado: (2023)

Key sunitinib‐related biomarkers for renal cell carcinoma
por: Peng, Yun, et al.
Publicado: (2021)

Expression of AOX1 Predicts Prognosis of Clear Cell Renal Cell Carcinoma
por: Xiong, Luyang, et al.
Publicado: (2021)

Sarcomatoid-associated gene risk index for clear cell renal cell carcinoma
por: Zuo, You, et al.
Publicado: (2022)

EMILIN2 is associated with prognosis and immunotherapy in clear cell renal cell carcinoma
por: Zhao, Guangjian, et al.
Publicado: (2022)

A novel marker based on necroptosis-related long non-coding RNA for forecasting prognostic in patients with clear cell renal cell carcinoma
por: Lv, Jinxing, et al.
Publicado: (2022)

A novel prognostic model based on six methylation-driven genes predicts overall survival for patients with clear cell renal cell carcinoma
por: Zhou, Hongmin, et al.
Publicado: (2022)

Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma
por: Weaver, Chaston, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_58ud6055hhdgrr4fpic3utvhkj